Publication Name	World Journal of Transplantation
Manuscript ID	72125
Country	United Kingdom

Received	2021-10-05 14:44
Peer-Review Started	2021-10-05 14:47
To Make the First Decision
Return for Revision	2021-12-16 10:05
Revised	2021-12-28 17:32
Second Decision	2022-01-19 03:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-01-20 05:09
Articles in Press	2022-01-20 05:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-01-28 07:38
Publish the Manuscript Online	2022-02-10 07:46

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Letter to the Editor
Article Title	Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation
Manuscript Source	Invited Manuscript
All Author List	Urvashi Singh, Baljit Singh and Maria Irene Bellini
ORCID	Author(s) ORCID Number Urvashi Singh http://orcid.org/0000-0003-2176-5750 Baljit Singh http://orcid.org/0000-0001-9713-0247 Maria Irene Bellini http://orcid.org/0000-0003-0730-4923
Funding Agency and Grant Number
Corresponding Author	Urvashi Singh, MBBS, MSc, N/A, N/A, Department of Surgery, Wythenshawe Hospital, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Manchester M23 9LT, United Kingdom. usingh01@qub.ac.uk
Key Words	Inflammatory bowel disease; Kidney transplantation; Steroids; Immunosuppression; Kidney failure; Ulcerative colitis; Crohn’s disease
Core Tip	Patients with inflammatory bowel disease (IBD) can develop extra-renal complications and as a result, suffer from end stage renal failure requiring kidney transplantation (KT). A brief review of available literature revealed that IBD patients undergoing KT have shorter overall survival rates compared to their controls. We highlight through our paper, previously reported survival outcomes and immunosuppressive regimens used in this cohort of patients through a brief literature review.
Publish Date	2022-02-10 07:46
Citation	Singh U, Singh B, Bellini MI. Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation. World J Transplant 2022; 12(2): 21-23
URL	https://www.wjgnet.com/2220-3230/full/v12/i2/21.htm
DOI	https://dx.doi.org/10.5500/wjt.v12.i2.21

Full Article (PDF)	WJT-12-21.pdf
Full Article (Word)	WJT-12-21.docx
Manuscript File	72125_Auto_Edited.docx
Answering Reviewers	72125-Answering reviewers.pdf
Audio Core Tip	72125-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	72125-Conflict-of-interest statement.pdf
Copyright License Agreement	72125-Copyright license agreement.pdf
Peer-review Report	72125-Peer-review(s).pdf
Scientific Misconduct Check	72125-Bing-Wang JJ-2.png
Scientific Editor Work List	72125-Scientific editor work list.pdf
CrossCheck Report	72125-CrossCheck report.pdf